In samples from various cohorts of patients with breast cancer, ERRα mRNA positively correlates with the expression of the oncogene ERBB2 and inversely correlates to that of ERα and PR, which are considered as good prognostic markers for patients with breast cancer (36). The gene discussed is PGR; the disease is breast carcinoma.